Published • loading... • Updated
Alector Maps Brain-Delivery Pipeline for Alzheimer’s, Parkinson’s Therapies
Summary by MarketBeat
2 Articles
2 Articles
Alector, Inc. (ALEC) Discusses Strategic Advances in Next Generation Neurodegeneration Therapies and Pipeline Developments Transcript
Alector, Inc. (ALEC) Discusses Strategic Advances in Next Generation Neurodegeneration Therapies and Pipeline Developments October 13, 2026 11:00 AM...
·Ra'anana, Israel
Read Full Article
Alector Maps Brain-Delivery Pipeline for Alzheimer’s, Parkinson’s Therapies
Alector (NASDAQ:ALEC) outlined its strategy to advance brain-penetrant therapies for neurodegenerative diseases, highlighting an anti-amyloid beta antibody for Alzheimer’s disease and two siRNA programs targeting tau and alpha-synuclein. Chief Executive Officer and co-founder Arnon Rosenthal said t
·Sioux Falls, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
